These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 22299710)
1. Bacterial resistance and impetigo treatment trends: a review. Bangert S; Levy M; Hebert AA Pediatr Dermatol; 2012; 29(3):243-8. PubMed ID: 22299710 [TBL] [Abstract][Full Text] [Related]
2. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950 [TBL] [Abstract][Full Text] [Related]
3. Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo. Thum D; Seidl HP; Hein R; Ring J; Andres C; Mempel M J Dtsch Dermatol Ges; 2013 Sep; 11(9):875-8. PubMed ID: 23621472 [No Abstract] [Full Text] [Related]
7. Treatment of impetigo: oral antibiotics most commonly prescribed. Bolaji RS; Dabade TS; Gustafson CJ; Davis SA; Krowchuk DP; Feldman SR J Drugs Dermatol; 2012 Apr; 11(4):489-94. PubMed ID: 22453587 [TBL] [Abstract][Full Text] [Related]
8. Impetigo update: new challenges in the era of methicillin resistance. Geria AN; Schwartz RA Cutis; 2010 Feb; 85(2):65-70. PubMed ID: 20349679 [TBL] [Abstract][Full Text] [Related]
9. Impetigo: an overview. Darmstadt GL; Lane AT Pediatr Dermatol; 1994 Dec; 11(4):293-303. PubMed ID: 7899177 [TBL] [Abstract][Full Text] [Related]
10. Topical antibiotic treatment of impetigo with tetracycline. Kuniyuki S; Nakano K; Maekawa N; Suzuki S J Dermatol; 2005 Oct; 32(10):788-92. PubMed ID: 16361729 [TBL] [Abstract][Full Text] [Related]
11. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. Vogel A; Lennon D; Best E; Leversha A N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855 [TBL] [Abstract][Full Text] [Related]
12. Impetigo - review. Pereira LB An Bras Dermatol; 2014; 89(2):293-9. PubMed ID: 24770507 [TBL] [Abstract][Full Text] [Related]
14. Treatment for impetigo. Brown E; Wise R Br J Gen Pract; 2003 Dec; 53(497):974. PubMed ID: 15002451 [No Abstract] [Full Text] [Related]
15. Topical Ozenoxacin Cream 1% for Impetigo: A Review. Schachner L; Andriessen A; Bhatia N; Grada A; Patele D J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625 [TBL] [Abstract][Full Text] [Related]
16. Impetigo: A need for new therapies in a world of increasing antimicrobial resistance. D'Cunha NM; Peterson GM; Baby KE; Thomas J J Clin Pharm Ther; 2018 Feb; 43(1):150-153. PubMed ID: 29063621 [TBL] [Abstract][Full Text] [Related]
17. A primer on topical antibiotics for the skin and eyes. Noah S J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527 [TBL] [Abstract][Full Text] [Related]
18. Treatment of uncomplicated skin and skin infections in the pediatric and adolescent patient populations. Schachner LA J Drugs Dermatol; 2005; 4(6 Suppl):s30-3. PubMed ID: 16300228 [TBL] [Abstract][Full Text] [Related]
19. Systemic or topical treatment for impetigo? Gunn H; Del Mar C Aust Fam Physician; 2003 Dec; 32(12):1022. PubMed ID: 14708154 [No Abstract] [Full Text] [Related]
20. Formaldehyde as an alternative to antibiotics for treatment of refractory impetigo and other infectious skin diseases. Nikolic P; Mudgil P; Whitehall J Expert Rev Anti Infect Ther; 2019 Sep; 17(9):681-687. PubMed ID: 31393185 [No Abstract] [Full Text] [Related] [Next] [New Search]